Navigation Links
Enhanced U.S. Efforts to Fight Tropical Disease Offer Hope to Millions of Patients

Pharmaceutical Companies' Donations of Medicines Remain Key Component

WASHINGTON, Feb. 22 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today released the following statement on President Bush's proposal to increase the United States' efforts to battle neglected tropical diseases in the developing world:

"America's pharmaceutical research companies applaud President Bush's proposal to increase the United States' commitment to fight neglected tropical diseases (NTDs) such as trachoma, schistosomiasis, and river blindness. Many of these diseases are preventable and treatable, and this tremendous support -- coupled with the ongoing efforts by pharmaceutical companies -- offers great hope that we can bring an end to the devastation they cause.

"Today, most drugs to treat these diseases are donated by pharmaceutical companies -- at an estimated value in the hundreds of millions of dollars annually. Beyond the direct therapeutic benefit for patients, the contributions of these drugs also have a meaningful economic impact on the battle against disease in the developing world. In Sub-Saharan Africa, these donations have helped to lower the estimated cost of an effective program to fight NTDs to less than 40 cents per person per year, according to the White House.

"Researchers and scientists from America's pharmaceutical research companies are proud to have worked to develop effective treatments for a wide range of NTDs, and will be honored to accept President Bush's challenge to increase global action in this fight. Together, we can combat NTDs and significantly improve the lives of families and communities across Africa."

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $43 billion in 2006 in discovering and developing new medicines. Industry-wide research and investment reached a record $55.2 billion in 2006.

PhRMA Internet Address:

For information on stories of hope and survival, visit:

For information on how innovative medicines save lives, visit:

For information on the Partnership for Prescription Assistance, visit:

For information on the danger of imported drugs, visit:

SOURCE Pharmaceutical Research and Manufacturers of America(PhRMA)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site
2. The HealthCentral Network and Sister to Sister Form Alliance to Develop Enhanced Online Resources
3. T cell immunity enhanced by timing of interleukin-7 therapy
4. Brookdale Senior Living Announces Enhanced Web Site
5. NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information
6. PreViser Launches New Website and Enhanced Version of Its Oral Disease and Risk Assessment Software
7. The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain
8. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
9. Enhanced PrecyseCode 2X(TM) Further Accelerates Remote Coding and Improves Cash Flow for Hospitals
10. EDAP Launches Enhanced Communication Plans at SIU Paris Congress
11. Greenway Medical Technologies Broadens Sales Efforts With Entrance Into Federally Qualified Health Center Marketplace
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from reveals that behind the tendency to ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... a startling report released today, National Safety Council research ... proven plan to eliminate prescription opioid overdoses. Prescription Nation ... tackling the worst drug crisis in recorded U.S. history, assigned a ... , New Mexico , Tennessee ... failing states, three – Michigan , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
Breaking Medicine Technology: